Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Triple-Target Incretin Drug Kills Knee Osteoarthritis Pain in Obesity

(MedPage Today) -- ORLANDO -- The investigational obesity drug retatrutide was highly effective in reducing pain and improving disability in knee osteoarthritis (OA) associated with obesity, according to the TRIUMPH-4 trial. Among patients in...

Triple-Target Incretin Drug Kills Knee Osteoarthritis Pain in Obesity

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Sunday 8 November →